Home » Tenders » Americas » Brazil » Registration of Prices for Future and Eventual Pharmacological Material, to... Tender

Registration of Prices for Future and Eventual Pharmacological Material, to Meet... Tender

Download Documents

DEFENSE MINISTRY has floated a tender for Registration of Prices for Future and Eventual Pharmacological Material, to Meet the Needs of Esfcex (Suppliers Consider the Description of the Items to Compose the Proposals, only T.... The project location is Brazil and the tender is closing on 18 Mar 2024. The tender notice number is 90001/2024, while the TOT Ref Number is 98324859. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Brazil

Summary : Registration of Prices for Future and Eventual Pharmacological Material, to Meet the Needs of Esfcex (Suppliers Consider the Description of the Items to Compose the Proposals, only T...

Deadline : 18 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98324859

Document Ref. No. : 90001/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEFENSE MINISTRY
Rua Territorio do Amapa, Nr. 455 - Pituba - Pituba - Salvador (BA)
Brazil

Tender Details

Object: Electronic Auction - Recording of prices for future and eventual pharmacological material, to meet the needs of ESFCEx (suppliers consider the description of the items to compose the proposals, only that of the Terms of Reference, in case of divergence

UASG Code: 160525

Edi19981d172c851bd4e8a1788d5726c2d3such as from: 03/06/2024 from 09:00 to 12:00 pm and from 13:30 to 16:30 pm

Proposal Delivery: from 03/06/2024 at 09:00 pm

ACETYLCYSTEINE, DOSAGE 600 MG, INDICATION POWDER FOR ORAL SOLUTION

Quantity: 1500

ACETYLSALICYLIC ACID, CONCENTRATION 100 MG, PHARMACEUTICAL FORM ENTERIC RELEASE

Quantity19981d172c851bd4e8a1788d5726c2d3age: 200

ASCORBIC ACID, DOSAGE 100 MG/ML, INJECTABLE USE TYPE

Quantity: 300

DISTILLED WATER, STERILE AND APIROGENIC PHYSICAL APPEARANCE, CLOSED SYSTEM PACKAGING TYPE

Quantity: 400

ALBENDAZOLE, CONCENTRATION 400 MG, PHARMACEUT FORM ICA CHEWABLE TABLET

Quantity: 900

AMBROXOL, COMPOSITION19981d172c851bd4e8a1788d5726c2d3HYCLORHYDRATE SALT, CONCENTRATION 7.5 MG/ML, ORAL SOLUTION APPLICATION

Quantity: 300

AMOXICILLIN, ACTIVE INGREDIENT ASSOCIATED WITH POTASSIUM CLAVULANATE, CONCENTRATION 875MG 125MG

Quantity: 1400

BETAMETHASONE, DIPROPIONATE COMPOSITION, ASSOCIATED WITH KETOCONAZOLE AND NEOMICIN A, CONCENTRATION 0 .5 MG/G 20 MG19981d172c851bd4e8a1788d5726c2d3/G 1.5 MG/G, PHARMACEUTICAL FORM CREAM

Quantity: 200

BROMOPRIDE, DOSAGE 5 MG/ML, INJECTABLE PRESENTATION

Quantity: 200

KETOPROFEN, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 300

KETOPROFEN, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE

Quantity19981d172c851bd4e8a1788d5726c2d3ade: 400

CYCLOBENZAPRINE HYCLORHYDRATE, DOSAGE 5 MG

Amount: 200

CLONAZEPAM, DOSAGE 0.5 MG

Amount: 200

SODIUM CHLORIDE, CONCENTRATION 0.9%, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Amount: 400

SODIUM CHLORIDE, CONCENTRATION 0.9%, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 600

CHLOR19981d172c851bd4e8a1788d5726c2d3SODIUM ETO, CONCENTRATION 0.9%, PHARMACEUTICAL FORM INJECTIVE SOLUTION...